MPLT SCHEDULE 13G: SEC filing
A joint filing agreement was
Filed with the SEC on · accession 0001012975-26-000807
MPLT filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 20, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -7.6% by the first close after the filing.
Summary of the filing
A joint filing agreement was filed as an exhibit to a Schedule 13G by a group of affiliated Nan Fung/Pivotal entities, allowing them to file ownership reports jointly regarding MapLight Therapeutics securities.
Key details
How MPLT stock reacted
Close before
$12.15
Aug 19, 2026
First close after
-7.57%
$11.23
5 trading days
+5.84%
$12.86
Since filing
-43.95%
$6.81
✦ Ask GOAX AI about this filing — what it means for MPLT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MPLT?
Click hereFrequently asked questions
What did MPLT file with the SEC on Aug 20, 2026?
MPLT filed a SCHEDULE 13G (SEC filing). A joint filing agreement was filed as an exhibit to a Schedule 13G by a group of affiliated Nan Fung/Pivotal entities, allowing them to file ownership reports jointly regarding MapLight Therapeutics securities.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did MPLT stock react to this filing?
MPLT closed at $12.15 before the filing and $11.23 on Aug 20, 2026 (-7.57%). Five trading days later: $12.86 (+5.84%).
Other MPLT SEC filings
- EFFECT · SEC filingSep 23, 2026
- 424B3 · Secondary offeringSep 23, 2026
- S-1 · SEC filingSep 18, 2026
- S-1 · SEC filingSep 9, 2026
- 8-K · Secondary offeringAug 13, 2026
- 10-Q · SEC filingAug 13, 2026
- 8-K · Fda approvalJul 27, 2026
- 8-K · Board changeJun 24, 2026
- 8-K · Fda approvalJun 22, 2026
- 8-K · Cfo changeJun 18, 2026
Get alerts when MPLT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days